Boswellia: Joint Pain Evidence from Frankincense Extracts
Joint Pain Evidence from Frankincense Extracts
Boswellia looks most plausible as a symptom-modifying add-on for knee osteoarthritis, but the evidence depends heavily on extract standardization, small trials, and realistic tracking of pain and function.
Quick answer
A reasonable trial has a defined product, baseline tracking, a symptom target, and a stop rule if benefit is absent or adverse effects appear.
Key takeaways
- The Viral Promise
- What Boswellia Is
- Mechanism Ladder
- First Boundary
- Clinical Evidence
- Cartilage Claims
How it works
- Boswellia has plausible anti-inflammatory chemistry and some knee osteoarthritis trial signals, but the overall evidence is mixed and product-specific.
- Reviews find possible improvement in WOMAC and VAS scores, especially versus placebo, but heterogeneity prevents a simple universal effect estimate.
- NCCIH cautions that store supplements may differ from tested products; Boswellia trials often use proprietary or standardized extracts.
What the evidence says
Best evidence
knee OA symptoms
Claims outrun certainty
Extract identity matters
Safety and who should ask first
- Government supplement guidance emphasizes that products may interact with medicines and can matter before surgery or with medical conditions.
- Because tested products may differ from commercial products, label transparency and third-party quality checks matter more than broad herb claims.
- Trial tolerability is reassuring but limited; supplement safety still depends on individual conditions, medicines, procedures, and product quality.
References
- Dietary Supplement Fact Sheets — NIH Office of Dietary Supplements
- Using Dietary Supplements Wisely — National Center for Complementary and Integrative Health
- FDA 101: Dietary Supplements — U.S. Food and Drug Administration
Related guides
Body Ladder is educational only. It does not diagnose, treat, or replace care from a qualified clinician.